The current strategy for the treatment of venous trophic ulcers (VTU) suggests differentiated approach and a combination of conservative and surgical methods. This paper presents the results of the study of efficacy of systemic enzyme therapy (Phlogenzym by Mucos Pharma, Germany) in patients with varicose veins of lower extremities (CEAP class C6) and stage I, II and III VTU. The study included 38 patients aged 12 to 82 years. The patients were divided into the experimental (n = 20) and the control (n = 18) groups. The treatment lasted 1 month. Silcofix Professional wound dressings (Pharmaplast, Egypt) were used. All patients received Detralex (Les Laboratoires Servier, France) and wore class 2 and 3 knee-high compression socks. Patients of the experimental group also received Phlogenzym for 30 days (3 tablets 3 times a day). Total ulcer epithelization was observed in 8 (40 %) patients by week 3, and in 18 (90 %) patients by the end of treatment compared to 4 (22 %) and 9 (50 %) patients in the control group, respectively. In the control group, the regenerative process in the area of the ulcerous defect was less prominent compared to the experimental group. Immunoassays revealed a significant reduction in CD4<sup>+</sup>CD25<sup>Bright</sup> cells and increased levels of CD4<sup>+</sup>CD45RO<sup>+</sup> T-lymphocytes in the experimental group, corresponding with the observed positive clinical response. The use of immunomodulatory drug Phlogenzym contributed to a more rapid regression of clinical symptoms of chronic venous insufficiency and faster healing of stage I–III venous trophic ulcers.
VIEWS 3596
The article presents the analysis of clinical and angiographic characteristics and risk factors of myocardial infarction (MI) in men and women aged <45 years. The study included 35 patients with acute MI (15 females, 20 males) of the 14th Department of Cardiology, N. I. Pirogov City Clinical Hospital No. 1 (Moscow). The average age of female and male patients was 41.2 and 39.6 years, respectively. The majority of patients of both sexes had ST-elevation MI (STEMI) (88.6 %), among which Q-wave MI accounted for 60.0 % of cases and typical MI accounted for 71.4 % of cases. Forty percent of patients of both sexes had no previous history of CHD. Almost all risk factors (dyslipidemia, hypertension, early family history etc.) were seen more often in women compared to men, except smoking which was found to be a risk factor in 55 % of men vs. 6 % of women (p <0.05). The coronary angiography data showed the prevalence of the right type of coronary circulation (70 % of patients) and single-vessel disease (80 %) with coronary stenosis of more than 75 %. The time to diagnosis was 2.1 times greater in women than in men accounting for an average of 9.2 and 4.3 hours, respectively. The main causes of delayed MI diagnosis before admittance were late patient referral or diagnostic errors.
VIEWS 3479